Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment.
Τίτλος | Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Tsourdi, E., Makras P., Rachner T. D., Polyzos S., Rauner M., Mandanas S., Hofbauer L. C., & Anastasilakis A. D. |
Journal | Bone |
Volume | 120 |
Pagination | 44-49 |
Date Published | 2019 Mar |
ISSN | 1873-2763 |
Abstract | PURPOSE: Prior osteoporosis therapies may affect the skeletal response to denosumab. We compared the effect of denosumab (60 mg every 6 months for 12 months) on bone mineral density and bone metabolism parameters in postmenopausal women with low bone mass who were either treatment-naïve (n = 30), or previously treated either with zoledronic acid (n = 30), or teriparatide (n = 22). |
DOI | 10.1016/j.bone.2018.10.001 |
Alternate Journal | Bone |
PubMed ID | 30292818 |